» Articles » PMID: 33506478

Patient Cohort Identification on Time Series Data Using the OMOP Common Data Model

Overview
Publisher Thieme
Date 2021 Jan 28
PMID 33506478
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The identification of patient cohorts for recruiting patients into clinical trials requires an evaluation of study-specific inclusion and exclusion criteria. These criteria are specified depending on corresponding clinical facts. Some of these facts may not be present in the clinical source systems and need to be calculated either in advance or at cohort query runtime (so-called feasibility query).

Objectives: We use the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) as the repository for our clinical data. However, Atlas, the graphical user interface of OMOP, does not offer the functionality to perform calculations on facts data. Therefore, we were in search for a different approach. The objective of this study is to investigate whether the Arden Syntax can be used for feasibility queries on the OMOP CDM to enable on-the-fly calculations at query runtime, to eliminate the need to precalculate data elements that are involved with researchers' criteria specification.

Methods: We implemented a service that reads the facts from the OMOP repository and provides it in a form which an Arden Syntax Medical Logic Module (MLM) can process. Then, we implemented an MLM that applies the eligibility criteria to every patient data set and outputs the list of eligible cases (i.e., performs the feasibility query).

Results: The study resulted in an MLM-based feasibility query that identifies cases of overventilation as an example of how an on-the-fly calculation can be realized. The algorithm is split into two MLMs to provide the reusability of the approach.

Conclusion: We found that MLMs are a suitable technology for feasibility queries on the OMOP CDM. Our method of performing on-the-fly calculations can be employed with any OMOP instance and without touching existing infrastructure like the Extract, Transform and Load pipeline. Therefore, we think that it is a well-suited method to perform on-the-fly calculations on OMOP.

Citing Articles

Augmenting the Hospital Score with social risk factors to improve prediction for 30-day readmission following acute myocardial infarction.

Ricket I, Matheny M, Reeves R, Shah R, Goodrich C, Gobbel G Med Res Arch. 2025; 12(11).

PMID: 39906889 PMC: 11788934. DOI: 10.18103/mra.v12i11.6089.


Implementation of the Observational Medical Outcomes Partnership Model in Electronic Medical Record Systems: Evaluation Study Using Factor Analysis and Decision-Making Trial and Evaluation Laboratory-Best-Worst Methods.

Luo M, Gu Y, Zhou F, Chen S JMIR Med Inform. 2024; 12:e58498.

PMID: 39331952 PMC: 11470222. DOI: 10.2196/58498.


Pregnancy Outcomes among Pregnant Persons after COVID-19 Vaccination: Assessing Vaccine Safety in Retrospective Cohort Analysis of U.S. National COVID Cohort Collaborative (N3C).

Faherty E, Wilkins K, Jones S, Challa A, Qin Q, Chan L Vaccines (Basel). 2024; 12(3.

PMID: 38543923 PMC: 10975285. DOI: 10.3390/vaccines12030289.


Operational Ontology for Oncology (O3): A Professional Society-Based, Multistakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data From Patients Treated for Cancer.

Mayo C, Feng M, Brock K, Kudner R, Balter P, Buchsbaum J Int J Radiat Oncol Biol Phys. 2023; 117(3):533-550.

PMID: 37244628 PMC: 10741247. DOI: 10.1016/j.ijrobp.2023.05.033.


A Standardized Clinical Data Harmonization Pipeline for Scalable AI Application Deployment (FHIR-DHP): Validation and Usability Study.

Williams E, Kienast M, Medawar E, Reinelt J, Merola A, Klopfenstein S JMIR Med Inform. 2023; 11:e43847.

PMID: 36943344 PMC: 10131740. DOI: 10.2196/43847.


References
1.
Kraus S . Generalizing the Arden Syntax to a Common Clinical Application Language. Stud Health Technol Inform. 2018; 247:675-679. View

2.
Ohno-Machado L, Wang S, Mar P, Boxwala A . Decision support for clinical trial eligibility determination in breast cancer. Proc AMIA Symp. 1999; :340-4. PMC: 2232554. View

3.
Hripcsak G . Writing Arden Syntax Medical Logic Modules. Comput Biol Med. 1994; 24(5):331-63. DOI: 10.1016/0010-4825(94)90002-7. View

4.
Meystre S, Heider P, Kim Y, Aruch D, Britten C . Automatic trial eligibility surveillance based on unstructured clinical data. Int J Med Inform. 2019; 129:13-19. PMC: 6717538. DOI: 10.1016/j.ijmedinf.2019.05.018. View

5.
Ross J, Tu S, Carini S, Sim I . Analysis of eligibility criteria complexity in clinical trials. Summit Transl Bioinform. 2011; 2010:46-50. PMC: 3041539. View